Weidang Wu
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
-
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Kruppel-like factors research 2
- Photosynthetic Processes and Mechanisms 2
- Epigenetics and DNA Methylation 2
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Changxiao Liu (8 shared papers)Xiulin Yi (8 shared papers)Yazhuo Li (5 shared papers)Jing Ji (3 shared papers)Jingyu Ran (2 shared papers)Ze Wang (1 shared paper)Yinghui Sun (1 shared paper)Lihua Xiao (2 shared papers)
- Journals
- Current Drug Metabolism (2 papers)Acta Pharmaceutica Sinica B (1 paper)Chemico-Biological Interactions (1 paper)Journal of Nephrology (1 paper)RSC Advances (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Weidang Wu
18 papers receiving 306 citations
Peers
Comparison fields: 5 of 76
- Nephrology 58
- Biochemistry 31
- Pharmacology 39
- Biochemistry 16
- Molecular Medicine 9
Countries citing papers authored by Weidang Wu
This map shows the geographic impact of Weidang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidang Wu more than expected).
Fields of papers citing papers by Weidang Wu
This network shows the impact of papers produced by Weidang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidang Wu. The network helps show where Weidang Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weidang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 69 | |
| 2 | 2019 | 44 | |
| 3 | 2016 | 29 | |
| 4 | 2013 | 29 | |
| 5 | 2015 | 23 | |
| 6 | 2018 | 20 | |
| 7 | 2020 | 17 | |
| 8 | 2015 | 14 | |
| 9 | 2012 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2015 | 10 | |
| 12 | 2024 | 9 | |
| 13 | 2019 | 7 | |
| 14 | 2015 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2018 | 3 | |
| 17 | [Screening and activity analysis of nanobodies against lymphocyte activation gene-3(LAG-3)]. | 2023 | 1 |
| 18 | 2025 | 1 |
About Weidang Wu
Weidang Wu is a scholar working on Molecular Biology, Oncology, Pharmacology, Pediatrics, Perinatology and Child Health and Biomaterials, having authored 18 papers that have together received 310 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Metal-Organic Frameworks: Synthesis and Applications (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Kruppel-like factors research (2 papers), Photosynthetic Processes and Mechanisms (2 papers), Traditional Chinese Medicine Analysis (2 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Nephrology (58 citations), Biochemistry (31 citations), Pharmacology (39 citations), Biochemistry (16 citations) and Molecular Medicine (9 citations). Weidang Wu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Changxiao Liu, Xiulin Yi, Yazhuo Li, Jing Ji, Jingyu Ran, Ze Wang, Yinghui Sun, Lihua Xiao, Rui Liu and Gang Wang. Their work appears in journals such as Current Drug Metabolism, Acta Pharmaceutica Sinica B, Chemico-Biological Interactions, Journal of Nephrology and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.